Atopic dermatitis - novel insights in the immunopathology of the disease
Srpski arhiv za celokupno lekarstvo · 2026 · 154 (5-6) · 372-378
DOI: 10.2298/sarh251119045j ↗Kurz gefasst
Fachartikel in der Zeitschrift Srpski arhiv za celokupno lekarstvo, 2026. Verfasst von Sanja Jakovljevic und 4 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Atopic dermatitis is an inflammatory skin disease that is characterized by a chronic-relapsing course and a pronounced feeling of itching. Altered production of structural proteins, lipids and antimicrobial peptides results in epidermal impairment, leading to the early onset of disease, more severe lesions and numerous comorbidities. Atopic dermatitis has recently been recognized as a systemic type 2 inflammation and emerging novel therapeutic modalities reflect sophisticated molecular and immunopathological pathways. The aim of this article is to provide a thorough review of the existing knowledge regarding the most significant immunological aspects of the development and progression of atopic dermatitis.
Zitieren
APA
Jakovljevic, S., Barjaktarovic, I., Jakovljevic, D., Levakov, O., & Vujanovic, L. (2026). Atopic dermatitis - novel insights in the immunopathology of the disease. Srpski arhiv za celokupno lekarstvo, 154(5-6), 372-378. https://doi.org/10.2298/sarh251119045j
Vancouver
Jakovljevic S, Barjaktarovic I, Jakovljevic D, Levakov O, Vujanovic L. Atopic dermatitis - novel insights in the immunopathology of the disease. Srpski arhiv za celokupno lekarstvo. 2026;154(5-6):372-378. doi:10.2298/sarh251119045j
BibTeX
@article{Jakovljevic2026,
author = {Jakovljevic, Sanja and Barjaktarovic, Iva and Jakovljevic, Dunja and Levakov, Olivera and Vujanovic, Ljuba},
title = {Atopic dermatitis - novel insights in the immunopathology of the disease},
journal = {Srpski arhiv za celokupno lekarstvo},
year = {2026},
volume = {154},
number = {5-6},
pages = {372--378},
doi = {10.2298/sarh251119045j}
}
EUVIMED